Stock of the Day - March 6, 2024

Icahn Enterprises (IEP)

$7.49

-$0.06 (-0.8%)

Market Cap: $5.07B

About Icahn Enterprises

Icahn Enterprises L.P., through its subsidiaries, engages in the investment, energy, automotive, food packaging, real estate, home fashion, and pharma businesses in the United States and Internationally.

The Investment segment invests its proprietary capital through various private investment funds. This segment provides investment advisory and other related services. The Energy segment refines and markets transportation fuels in the form of gasoline and diesel fuels, as well as renewable diesel; and manufactures nitrogen fertilizers in the form of urea ammonium nitrate and ammonia. The Automotive segment sells automotive parts and materials, and retailed merchandise; offers automotive repair and maintenance services; and leases real estate properties. The Food Packaging segment produces and sells cellulosic, fibrous, and plastic casings that are used to prepare and package processed meat products. The Real Estate segment is involved in the leasing of land, retail, office, and industrial properties; the development and sale of single-family homes; and the operation of country clubs. The Home Fashion segment manufactures, sources, markets, distributes, and sells home fashion consumer products. The Pharma segment offers pharmaceutical products and services. The company was incorporated in 1987 and is headquartered in Sunny Isles Beach, Florida.

Today's Trend

Icahn Enterprises L.P. (IEP) — shares are trading modestly higher after a busy news day. Investors are weighing a large dividend and a NAV increase against a disappointing GAAP loss and indications management has hedged recent gains.

Indicative Net Asset Value rose by $201M to about $3.4B as of March 31, signalling improvement in underlying asset values that supports the firm's intrinsic value. Icahn Enterprises L.P. (Nasdaq: IEP) Today Announced Its First Quarter 2026 Financial Results
The board declared a $0.50 quarterly dividend (ex-div May 18, pay Jun 25), implying a very high annualized yield (~25%), which can attract income-focused investors but may pressure the share price on the ex-dividend date. Icahn Enterprises Balances NAV Gains With Heavy Hedges
Icorp’s biopharma exposure: management says the first PAH trial patient dosing is expected in the next 60–90 days — a near-term binary that could boost NAV if safety/early efficacy are positive. Icahn Enterprises outlines first PAH trial patient dosing in next 60 to 90 days as NAV rises $201M
Management changes announced: CFO Ted Papapostolou was promoted to CEO and Robert Flint named CFO — signals continuity but introduces execution risk during leadership transition. Icahn Enterprises L.P. Announces Management Changes
Q1 results missed expectations: GAAP loss of ($0.71) vs. consensus $0.10 and revenue $2.21B below estimates — the miss and negative margins are the main drivers of near-term selling pressure. Icahn Enterprises (NASDAQ:IEP) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings, Stock Drops
Management and analysts note the firm has applied “heavy hedges” to lock in NAV gains — this can limit upside participation if assets continue to appreciate. Icahn Enterprises Balances NAV Gains With Heavy Hedges

Bottom line for investors: the big dividend and NAV improvement are supportive, but the earnings miss, negative GAAP EPS and hedging program explain the cautious market reaction. Watch the PAH trial milestone, ex-dividend timing (May 18) and any guidance/comments from new management for near-term catalysts.

← Previous Stock of the Day Next Stock of the Day →

Icahn Enterprises (IEP)

About Icahn Enterprises

Today's Trend

Recent News